In the FAME study, patients with multivessel coronary artery disease were randomly assigned to undergo percutaneous coronary intervention (PCI) guided by either angiography (in which case, all identified stenoses were revascularized) or fractional flow reserve (FFR; in which case, only stenoses with an FFR ≤0.80 were stented). The investigators now report the 5-year outcomes of the trial. Major adverse cardiac events (the primary end point) occurred in 31% of patients who underwent angiography-guided PCI and in 28% of patients who received FFR-guided PCI (P = 0.31). Moreover, fewer stents were placed in the angiography group (mean 1.9) than in the FFR group (mean 2.7; P <0.0001). The long-term safety and lower resource use mean that “FFR guidance of multivessel PCI should be the standard of care in most patients”, conclude the investigators.
References
van Nunen, L. X. et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 10.1016/S0140-6736(15)00057-4
Rights and permissions
About this article
Cite this article
Long-term FAME of FFR-guided revascularization. Nat Rev Cardiol 12, 622 (2015). https://doi.org/10.1038/nrcardio.2015.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2015.146